Linda G. Fleisher

Title: A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocol

The eREACH2 study evaluates a digital intervention for cancer genetic testing compared to traditional counseling, aiming to improve access and outcomes for at-risk patients.

A Randomized Non-Inferiority Trial of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2)

eREACH2 evaluates a digital alternative to genetic counseling for cancer genetic testing, finding it non-inferior for service uptake and anxiety but inconclusive for knowledge, with mixed outcomes for result disclosure.

The Next Evolution of Hereditary Cancer Genetic Testing Service Delivery: A Descriptive Study of a Primary Collaborative Care Model for Telegenetics

This study describes a telegenetics program that collaborates with local providers to improve access to cancer genetic testing, showing high provider participation and willingness to collaborate.

eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancer

eREACH evaluates digital alternatives to genetic counseling for metastatic cancer patients, finding non-inferiority in short-term outcomes for one GC visit or fully digital models.